SMAD4 and hepatocellular carcinoma: Several studies have exhibited the relationship between miR-146a and the risk of hepatocellular carcinoma, and demonstrated highly expressed miR-146a decreased the sensitivity of hepatoma cells to IFN-a treatment through targeting SMAD4, resulting in the suppression of apoptosis34.